Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cbd - search results
If you're not happy with the results, please do another search
CB2R agonists in the clinics: A treasure chest for treating inflammatory diseases
Researchers give an update on clinical trials with CB2R agonists and their potential for the treatment of inflammatory diseases.
A focus on Global Biodiversity Framework Target 7: Approaches to pollution
Dr Christoph Neumann analyses the Global Biodiversity Framework Target 7, and explains the need for a qualified risk-based approach to pollution from the COP15 convention.
Empowering wildlife conservation for a sustainable future
The International Council for Game and Wildlife Conservation (CIC) is a non-profit, international NGO that advocates for wildlife conservation through the sustainable use of natural resources.
The Psychedelic Renaissance: Exploring shifting attitudes towards psychedelic therapy
In a surprising turn of events, Prince Harry's public endorsement of the transformative power of psychedelic therapy has triggered a psychedelic resurgence in the UK.
Cannabis for cancer: Improving sleep and pain tolerance
Could cannabis for cancer become a reality in patient wards? Researchers find the plant can improve sleep, pain, and brain clarity, easing 'chemo brain'.
Targeting the Cannabinoid Type-2 Receptor for Novel Anto-inflammatory Therapeutics
Type-2 cannabinoid receptor (CB2R) is a G-protein-coupled receptor (GPCR) and an essential element of the endocannabinoid system (ECS) [1].
Peroxisomes, lipids, and neurodegeneration
Prof. Michael Schrader at the University of Exeter looks to understand the role of peroxisomes in human health and disease.
Biodiversity COP15 – A stepping stone towards effective access and benefit sharing
Here, Dominic Muyldermans and Markus Wyss explore the opportunities and challenges on the journey towards effective access and benefit sharing across the globe.
Dominic Muyldermans – ABSint
Dominic Muyldermans is the VP Legal for CropLife International.
He studied law in Leuven, Strasbourg and London. He has been advising on issues related to ABS for more than 10 years. He is a member of the ABS Task Force of the International Chamber of Commerce (ICC) and has been...
Exploring and understanding Egypt’s sustainable initiatives
Luma Saqqaf, CEO of Ajyal Sustainability Consulting, walks us through Egypt’s sustainable initiatives, especially Egypt Vision 2030.
Hold businesses accountable for protecting and restoring nature
Jenni Black, Nature Transformation Lead at the World Benchmarking Alliance, argues that we must hold businesses accountable for protecting and restoring nature.
An in-depth look at opioid dependence
Dr Gerard Sinovich, Lead Pain Specialist, provides an in-depth commentary on behalf of Cantourage Clinic concerning what we need to know about opioids and opioid dependence.
What is the ‘entourage effect’ of cannabis and how can it relieve pain?
The ‘entourage effect’ of cannabis comes from the pain-relieving effects of the plant, but could we boost this pain-relieving efficacy of THC without the psychoactive side effects?
Jade Proudman – Savage Cabbage
Jade Proudman is founder of Savage Cabbage, Global Ambassador for Charlotte’s Web, and a major voice in the CBD community.
Jade founded Savage Cabbage in 2016 after struggling to access high-quality CBD products from her home in the UK. A series of life-changing health issues led Jade to reach out...
Evaluating a novel treatment for opioid use disorder based on dual-brain psychology and photobiomodulation
Dr. Fredric Schiffer, founder and CEO of MindLight, LLC, looks at treatments for opioid use disorder based on Dual-Brain Psychology and photobiomodulation. Dr. Schiffer is also a part-time assistant professor in psychiatry at Harvard Medical School.
Open Science and Research Infrastructures provide the foundation and pillars necessary to tackle global...
COVID has highlighted the importance of Open Science and research infrastructures to accelerate the impact of scientific research.
Do you really need to be taking paracetamol?
Paracetamol is Britain’s most trusted painkiller with the average person taking up to 70 paracetamol per year, however there are safety issues.
A blueprint for the UK Cannabis Industry
Senior Associate David Hardstaff and Partner John Binns of BCL Solicitors LLP, share their views on a blueprint for the UK Cannabis Industry.
Cannabis may offer relief from menopause symptoms
Menopause symptoms, ranging from hot flashes to weight gain, can be eased with cannabis and CBD, research finds.
30% higher carbon emissions produced by deforestation than climate change
The Atlantic Rainforest’s carbon storage capacity has been affected by deforestation due to human activity – with carbon emissions worse than those produced by climate change.
